Company name | Market Cap | Profitability rating | Gross Profit margin (LTM) | EBIT margin (LTM) | EBITDA margin (LTM) | Net Income margin (LTM) | FCF margin (LTM) | Earnings quality (FCF to Net Income) |
$34.6B | 8.9 | 57.9% | 31.7% | 33.6% | 25.3% | 28.2% | 111.2% | |
$207.3B | 7.5 | 67.5% | 28.1% | 33.1% | 27.8% | 12.9% | 46.2% | |
$66.3B | 7.2 | 59.4% | 12.9% | 17.8% | 8.5% | 14.2% | 170.0% | |
$46.6B | 7.9 | 55.6% | 14.2% | 20.5% | 10.3% | 6.1% | 129.1% | |
$18.6B | 7.0 | 62.8% | 18.1% | 25.9% | 10.1% | 7.4% | 73.4% | |
$17.9B | 4.3 | 37.1% | (1.1%) | 7.4% | (5.0%) | 4.4% | (91.9%) | |
$16.9B | 6.8 | 34.6% | 19.9% | 25.6% | 17.0% | 9.6% | 56.1% | |
$14.7B | 8.7 | 56.2% | 23.9% | 30.2% | 18.4% | 28.1% | 152.6% | |
$10.4B | 4.0 | 48.0% | (12.7%) | (9.6%) | (14.6%) | 6.9% | (47.7%) | |
$9,757.8M | 7.3 | 48.7% | 14.1% | 21.1% | 10.5% | 9.7% | 93.3% | |
$8,979.7M | 5.8 | 46.9% | (0.8%) | 14.2% | (3.4%) | 21.3% | (633.3%) |
The ResMed Inc. (RMD) gross profit margin is 57.9%, compared to the industry median of 50.7% and the 5-year historical average of 57.3%.
The ResMed Inc. (RMD) operating income margin is 31.2%, compared to the industry median of 11.7%) and the 5-year historical average of 26.8%.
The ResMed Inc. (RMD) Free Cash Flow margin is 28.2%, compared to the industry median of 2.8% and the 5-year historical average of 17.9%.
The ResMed Inc. (RMD) earnings quality is 111.2%, compared to the industry median of 38.7% and the 5-year historical average of 89.3%.